Citations 1
Effect of prior hypomethylating agent (HMA) use on clinical outcome of patients (Pts) with secondary acute myeloid leukemia (sAML) arising from myelodysplastic syndrome (MDS) when treated with standard induction chemotherapy (7+3).
Subari, Salih , Baidoun, Firas , Hreh, Muhanad, Patnaik, Mrinal M. , Hashmi, Shahrukh, Elliott, Michelle A. , Litzow, Mark R. , Al‐Kali, Aref , Hogan, William J. , Baidoun, Firas
Journal of Clinical Oncology | March 7, 2019 | Volume: 33 | Issue: 15_suppl | Pages: e18041-e18041
